Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1993 Aug;37(8):1670–1673. doi: 10.1128/aac.37.8.1670

Comparison of ciprofloxacin and ceftriaxone as single-dose therapy for uncomplicated gonorrhea in women.

E W Hook 3rd 1, R B Jones 1, D H Martin 1, G A Bolan 1, T F Mroczkowski 1, T M Neumann 1, J J Haag 1, R Echols 1
PMCID: PMC188039  PMID: 8215281

Abstract

Although women bear the brunt of gonococcal infection-related morbidity, few large studies of gonorrhea treatment in women have been conducted. In a multicenter, double-blind, placebo-controlled trial, 181 evaluable women with uncomplicated gonorrhea were treated with ciprofloxacin (250 mg orally; 94 women) or ceftriaxone (250 mg intramuscularly; 87 women). Twenty-four percent of the participants were infected with antibiotic-resistant Neisseria gonorrhoeae. Cervical gonorrhea was cured in 100% (93 of 93) of the women treated with ciprofloxacin and 99% (83 of 84) receiving ceftriaxone. All pharyngeal (n = 5) or rectal (n = 20) infections treated with ciprofloxacin were cured, as were ceftriaxone-treated patients with pharyngeal (n = 6) or rectal (n = 21) infection. Geometric mean MICs (range) for 248 pretreatment isolates were: penicillin, 0.28 (0.015 to 8.0); tetracycline, 0.46 (0.06 to 4); ciprofloxacin, 0.003 (0.002 to 0.015); and ceftriaxone, 0.004 (0.001 to 0.125) microgram/ml. Both drugs were well tolerated. Despite the high prevalence of antibiotic-resistant gonococci in these populations, 250 mg of oral ciprofloxacin was as effective as an injection of ceftriaxone.

Full text

PDF
1673

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boslego J. W., Tramont E. C., Takafuji E. T., Diniega B. M., Mitchell B. S., Small J. W., Khan W. N., Stein D. C. Effect of spectinomycin use on the prevalence of spectinomycin-resistant and of penicillinase-producing Neisseria gonorrhoeae. N Engl J Med. 1987 Jul 30;317(5):272–278. doi: 10.1056/NEJM198707303170504. [DOI] [PubMed] [Google Scholar]
  2. Clendennen T. E., 3rd, Hames C. S., Kees E. S., Price F. C., Rueppel W. J., Andrada A. B., Espinosa G. E., Kabrerra G., Wignall F. S. In vitro antibiotic susceptibilities of Neisseria gonorrhoeae isolates in the Philippines. Antimicrob Agents Chemother. 1992 Feb;36(2):277–282. doi: 10.1128/aac.36.2.277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Clendennen T. E., Echeverria P., Saengeur S., Kees E. S., Boslego J. W., Wignall F. S. Antibiotic susceptibility survey of Neisseria gonorrhoeae in Thailand. Antimicrob Agents Chemother. 1992 Aug;36(8):1682–1687. doi: 10.1128/aac.36.8.1682. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Laughon B. E., Ehret J. M., Tanino T. T., Van der Pol B., Handsfield H. H., Jones R. B., Judson F. N., Hook E. W., 3rd Fluorescent monoclonal antibody for confirmation of Neisseria gonorrhoeae cultures. J Clin Microbiol. 1987 Dec;25(12):2388–2390. doi: 10.1128/jcm.25.12.2388-2390.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Loo P. S., Ridgway G. L., Oriel J. D. Single dose ciprofloxacin for treating gonococcal infections in men. Genitourin Med. 1985 Oct;61(5):302–305. doi: 10.1136/sti.61.5.302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Magder L. S., Harrison H. R., Ehret J. M., Anderson T. S., Judson F. N. Factors related to genital Chlamydia trachomatis and its diagnosis by culture in a sexually transmitted disease clinic. Am J Epidemiol. 1988 Aug;128(2):298–308. doi: 10.1093/oxfordjournals.aje.a114970. [DOI] [PubMed] [Google Scholar]
  7. O'Callaghan C. H., Morris A., Kirby S. M., Shingler A. H. Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate. Antimicrob Agents Chemother. 1972 Apr;1(4):283–288. doi: 10.1128/aac.1.4.283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Rajan V. S., Sng E. H., Thirumoorthy T., Goh C. L. Ceftriaxone in the treatment of ordinary and penicillinase-producing strains of Neisseria gonorrhoeae. Br J Vener Dis. 1982 Oct;58(5):314–316. doi: 10.1136/sti.58.5.314. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Reichart C. A., Neumann T., Foreman P., Zenilman J. M., Hook E. W., 3rd Temporal trends in gonococcal antibiotic resistance in Baltimore. Sex Transm Dis. 1992 Jul-Aug;19(4):213–218. doi: 10.1097/00007435-199207000-00006. [DOI] [PubMed] [Google Scholar]
  10. Roddy R. E., Handsfield H. H., Hook E. W., 3rd Comparative trial of single-dose ciprofloxacin and ampicillin plus probenecid for treatment of gonococcal urethritis in men. Antimicrob Agents Chemother. 1986 Aug;30(2):267–269. doi: 10.1128/aac.30.2.267. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Schwarcz S. K., Zenilman J. M., Schnell D., Knapp J. S., Hook E. W., 3rd, Thompson S., Judson F. N., Holmes K. K. National surveillance of antimicrobial resistance in Neisseria gonorrhoeae. The Gonococcal Isolate Surveillance Project. JAMA. 1990 Sep 19;264(11):1413–1417. [PubMed] [Google Scholar]
  12. Shahmanesh M., Shukla S. R., Phillips I., Westwood A., Thin R. N. Ciprofloxacin for treating urethral gonorrhoea in men. Genitourin Med. 1986 Apr;62(2):86–87. doi: 10.1136/sti.62.2.86. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. van der Willigen A. H., van der Hoek J. C., Wagenvoort J. H., van Vliet H. J., van Klingeren B., Schalla W. O., Knapp J. S., van Joost T., Michel M. F., Stolz E. Comparative double-blind study of 200- and 400-mg enoxacin given orally in the treatment of acute uncomplicated urethral gonorrhea in males. Antimicrob Agents Chemother. 1987 Apr;31(4):535–538. doi: 10.1128/aac.31.4.535. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES